JDRF’s nPOD Program Expands to Europe

JDRF’s nPOD program has been a remarkable success in advancing research into the causes of type 1 diabetes since its launch in the United States in 2007. The program (nPOD stands for Network for Pancreatic Organ Donors with Diabetes) has been funded by JDRF for an additional three-year period. It is also being expanded to Europe, which will provide researchers with an additional pool of potential organ donors—including the important but less-studied group with prediabetes. One of JDRF’s most important resources for scientists, nPOD provides the international type 1 diabetes research community with access to human pancreatic tissues from organ donors at all stages of the disease; researchers use the tissues to explore key questions about the underlying cause of type 1 diabetes. nPOD has made remarkable progress in increasing the number of organ donors screened for type 1 diabetes autoantibodies. By 2011, it is expected to be performing autoantibody screens on about 30% of all organ donors in the U.S., which will be a key milestone in nPOD’s and JDRF’s list of accomplishments.